Parallax Volatility Advisers
VYGR icon

Parallax Volatility Advisers’s Voyager Therapeutics VYGR Stock Holding History

Parallax Volatility Advisers’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,226
Closed -$37K – 4379
2017
Q4 		$37K Buy
+2,226
New +$38.2K ﹤0.01% 3377

Other funds holding VYGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Parallax Volatility Advisers's VYGR Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Voyager Therapeutics (VYGR) in Q1 2018, closing a stake of 2,226 shares — an estimated $37K sold.

Parallax Volatility Advisers first reported a position in VYGR in Q4 2017 and held it in 1 quarter. The position peaked at $37K in Q4 2017. 108 funds tracked by Wall St. Rank hold VYGR as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Voyager Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,226 Voyager Therapeutics shares in Q1 2018, an estimated $37K.
  • Parallax Volatility Advisers first reported a position in Voyager Therapeutics in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Voyager Therapeutics position peaked at $37K in Q4 2017.
  • 108 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.